Core Viewpoint - Northeast Pharmaceutical is focusing on market trends, leveraging its two core sales segments, raw materials and formulations, to achieve significant results and ensure stable performance for the company [1] Raw Material Segment - Northeast Pharmaceutical is a key global supplier of raw materials, enhancing its international market competitiveness, particularly in the EU and Japan/Korea, with market share increasing year by year [2] - The raw material sales company demonstrated strong market capabilities in Q4, with profits exceeding planned targets for two consecutive months in October and November, particularly in November [2] - Key products such as Vitamin C and L-Carnitine exceeded sales targets, while other products like Amantadine and Piracetam also performed well, enhancing the product matrix's competitiveness [2] - The company actively participated in major industry exhibitions to connect with core customer needs and adjust market strategies based on competitor insights [2][3] Formulation Segment - Northeast Pharmaceutical's formulation products rank first in domestic sales, contributing to economic benefits and enhancing brand recognition [4] - The formulation sales company is focusing on maintaining and expanding the market competitiveness of key products, with systematic planning for products like Gut Health and Pain Relief tablets [4] - Efficient execution and collaboration among teams have led to achieving monthly performance targets, providing confidence for year-end goals [4][5] Expansion into New Fields - In Q4, Northeast Pharmaceutical made significant strides in the health sector by launching new products such as health biscuits and advancing the development of additional health-oriented snacks [6] - The company is exploring the beauty sector with functional skincare products, leveraging its pharmaceutical-grade standards in product development [6] - The company aims to optimize its health product matrix and explore comprehensive health services, creating new growth points [6]

Core Insights - The company is focusing on market trends, with its two core sales segments, raw materials and formulations, playing a significant role in stabilizing performance and achieving important results in market penetration [1][2] - The company is actively expanding in the health sector, launching new products that contribute to comprehensive health services, providing confidence and direction for future work [1][4] Raw Material Segment - The company is a key global supplier of raw materials, enhancing its international market competitiveness, particularly in the EU and Japan, with market share increasing year by year [1][2] - In Q4, the raw material sales company demonstrated strong market capabilities, exceeding profit targets in October and November, with notable performance in November [1][2] - Key products such as Vitamin C and L-Carnitine significantly outperformed sales targets, indicating a strengthening product matrix [1][2] Market Expansion and Management - The raw material sales company has actively participated in major industry exhibitions to engage with core customers and align market orders, while also monitoring industry trends and competitor dynamics [2] - Internal management has been enhanced, with a focus on accountability and improving business capabilities, leading to effective collaboration across departments [2] Formulation Segment - The company has several formulation products that rank first in domestic sales, contributing to economic benefits and enhancing brand recognition [3] - A systematic approach has been adopted to boost sales of key products, with effective execution leading to monthly performance improvements [3] New Product Development - In Q4, the company made significant strides in the health sector by launching new products such as health-oriented biscuits, while also developing additional products to meet diverse health needs [4] - The company is leveraging its experience in R&D and quality control to explore the health food sector, including functional skincare products that integrate pharmaceutical technology [4][5] Strategic Focus - The company aims to leverage its comprehensive advantages in innovation, resource allocation, and market positioning to optimize its health product matrix and explore new growth points in the health sector [5]

点击上图▲立即收听 " 2020 年，大众的健康消费行为以 ' 朋克养生 ' 为主，到 2025 年已然进阶成 ' 悦养身心 ' ，短短四个字，情绪在如今消费决策中的权重不言而喻。 " 文 /巴九灵（微信公众号：吴晓波频道） 在社媒平台上，一种新的社交语言在兴起。 "今天吃逍遥丸了吗""气血不足，六味地黄丸安排上""普瑞巴林救我狗命，焦虑发作时它比男朋友管用"…… 图 源：小 红书 这些本该出现在医院处方笺上的药品，如今成了年轻人的情绪代餐、身份标签甚至是社交货币。 据CBNData调研数据，在习惯、情绪与环境的三重夹击下，88%的年轻人开始主动用药品、健康消费品进行"自救式健康管理"。 健康，成为了价值观、世界观、人生观之外的"第四观"，自嘲"脆皮青年"的年轻人正在用一套全新的逻辑，认真管理自己的身体。 那么，"身体脆一点，情绪更脆一点"的年轻人钱包里，究竟藏着一张怎样的情绪账单？ 最近，盖洛普与世界卫生峰会联合发布的《2025年世界情绪健康状况》报告显示，2024年有39%的成年人坦言自己经历着大量担忧，37%的人感 到压力重重，其次还有身体疼痛（32%）、悲伤（26%）和愤怒（22%）。而且，这些指标明 ...